Citi Pharma Limited (PSX:CPHL)
71.86
-0.30 (-0.42%)
At close: Oct 2, 2026
| Market Cap | 16.42B -27.6% |
| Revenue (ttm) | 13.84B +6.7% |
| Net Income | 1.10B +32.0% |
| EPS | 4.80 +31.9% |
| Shares Out | 228.46M |
| PE Ratio | 14.97 |
| Forward PE | n/a |
| Dividend | 3.50 (4.87%) |
| Ex-Dividend Date | Oct 17, 2025 |
| Volume | 148,413 |
| Open | 72.64 |
| Previous Close | 72.16 |
| Day's Range | 71.12 - 72.84 |
| 52-Week Range | 68.81 - 102.60 |
| Beta | 0.39 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 3, 2026 |